Cortisone acetate (brand names Adreson, Cortison, Cortisone, Cortisone Acetate, Cortone, Cortistab, Cortisyl, others) is a synthetic glucocorticoid corticosteroid and corticosteroid ester which is marketed (under prescription) in many countries throughout the world, including in the United States, the United Kingdom, and various other European countries.[1][2][3] It is the C21 acetate ester of cortisone,[1][2] and acts as a prodrug of cortisone in the body.[4]
Clinical data | |
---|---|
Trade names | Adreson, Cortison, Cortisone, Cortisone Acetate, Cortone, Cortistab, Cortisyl, others |
Other names | Cortisone 21-acetate; 17α,21-Dihydroxypregn-4-ene-3,11,20-trione 21-acetate |
Drug class | Corticosteroid; Glucocorticoid |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.006 |
Chemical and physical data | |
Formula | C23H30O6 |
Molar mass | 402.487 g·mol−1 |
3D model (JSmol) | |
| |
|
References
edit- ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 317–. ISBN 978-1-4757-2085-3.
- ^ a b Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 276–. ISBN 978-3-88763-075-1.
- ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 85–. ISBN 978-94-011-4439-1.
- ^ Løvås K, Husebye ES (December 2003). "Replacement therapy in Addison's disease". Expert Opinion on Pharmacotherapy. 4 (12): 2145–2149. doi:10.1517/14656566.4.12.2145. PMID 14640913. S2CID 37628998.